Synonym
Tetrahydropalmatine; Rotundine; L-Tetrahydropalmatine; (-)-Tetrahydropalmatine; (S)-Tetrahydropalmatine; Caseanine;
IUPAC/Chemical Name
(13aS)-2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline
InChi Key
AEQDJSLRWYMAQI-KRWDZBQOSA-N
InChi Code
InChI=1S/C21H25NO4/c1-23-18-6-5-13-9-17-15-11-20(25-3)19(24-2)10-14(15)7-8-22(17)12-16(13)21(18)26-4/h5-6,10-11,17H,7-9,12H2,1-4H3/t17-/m0/s1
SMILES Code
COC1=C(OC)C2=C(C=C1)C[C@]3([H])N(CCC4=C3C=C(OC)C(OC)=C4)C2
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
355.43
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Zhao Y, Liang A, Zhang Y, Li C, Yi Y, Nilsen OG. Impact of Tetrahydropalmatine on the Pharmacokinetics of Probe Drugs for CYP1A2, 2D6 and 3A Isoenzymes in Beagle Dogs. Phytother Res. 2016 Jun;30(6):906-14. doi: 10.1002/ptr.5608. Epub 2016 Mar 17. Review. PubMed PMID: 26990021.
2: Doosti F, Dashti S, Tabatabai SM, Hosseinzadeh H. Traditional Chinese and Indian medicine in the treatment of opioid-dependence: a review. Avicenna J Phytomed. 2013 Summer;3(3):205-15. Review. PubMed PMID: 25050276; PubMed Central PMCID: PMC4075718.
3: Desgrouas C, Taudon N, Bun SS, Baghdikian B, Bory S, Parzy D, Ollivier E. Ethnobotany, phytochemistry and pharmacology of Stephania rotunda Lour. J Ethnopharmacol. 2014 Jul 3;154(3):537-63. doi: 10.1016/j.jep.2014.04.024. Epub 2014 Apr 25. Review. PubMed PMID: 24768769.
4: Wang JB, Mantsch JR. l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction. Future Med Chem. 2012 Feb;4(2):177-86. doi: 10.4155/fmc.11.166. Review. PubMed PMID: 22300097; PubMed Central PMCID: PMC3878639.
5: Shorter D, Kosten TR. Novel pharmacotherapeutic treatments for cocaine addiction. BMC Med. 2011 Nov 3;9:119. doi: 10.1186/1741-7015-9-119. Review. PubMed PMID: 22047090; PubMed Central PMCID: PMC3216852.
6: Chu H, Jin G, Friedman E, Zhen X. Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction. Cell Mol Neurobiol. 2008 Jun;28(4):491-9. Epub 2007 Aug 21. Review. PubMed PMID: 17710533.
7: Zhu XZ. Development of natural products as drugs acting on central nervous system. Mem Inst Oswaldo Cruz. 1991;86 Suppl 2:173-5. Review. PubMed PMID: 1841995.
8: Jin GZ. [Progress in studies of the pharmacology of l-tetrahydropalmatine and l-stepholidine]. Yao Xue Xue Bao. 1987 Jun;22(6):472-80. Review. Chinese. PubMed PMID: 2897152.
